Hepatitis B surface antigen (HBsAg) prevalence (%) in Grenada
Grenada: Hepatitis B surface antigen (HBsAg) prevalence was 0.2% in 2024. ▼ Falling
Latest (2024)
0.2%
Change on year
unchanged
World rank
82nd
of 194 countries
All-time high
0.4%
in 2015
All-time low
0.2%
in 2018
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Grenada, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Grenada is 0.2%, measured in 2024. That is the lowest value across all 10 years on record.
The figure is down 50.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Grenada peaked at 0.4% in 2015 and was at its lowest, 0.2%, in 2018.
Grenada ranks 82nd of 194 countries on this measure, in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Grenada, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.2% | -33.3% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.2% | +0.0% |
| 2021 | 0.2% | +0.0% |
| 2022 | 0.2% | +0.0% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
Grenada compared with similar countries
- Grenada's 0.2% is above the median for upper middle income countries, which is 0.2%, 1.0× the median. (57 countries reporting)
- Grenada's 0.2% is above the median for Latin America & Caribbean, which is 0.1%, 2.0× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.4% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near Grenada
- 82 Tajikistan 0.2% compare
- 82 Saint Vincent and the Grenadines 0.2% compare
- 82 Venezuela 0.2% compare
- 82 Antigua and Barbuda 0.2% compare
- 82 Bahamas 0.2% compare
- 82 Barbados 0.2% compare
- 82 Dominica 0.2% compare
- 82 Fiji 0.2% compare
- 82 India 0.2% compare
- 82 Jamaica 0.2% compare
- 82 Kazakhstan 0.2% compare
- 82 Saint Kitts and Nevis 0.2% compare
- 82 Libya 0.2% compare
- 82 Saint Lucia 0.2% compare
- 82 Maldives 0.2% compare
- 82 North Macedonia 0.2% compare
- 82 Nepal 0.2% compare
- 82 Pakistan 0.2% compare
More health data for Grenada
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0116 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,727 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.69 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0283 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Grenada?
- Hepatitis b surface antigen (hbsag) prevalence in Grenada was 0.2% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Grenada?
- The highest recorded value was 0.4% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Grenada?
- The lowest recorded value was 0.2% in 2018.
- How does Grenada rank for hepatitis b surface antigen (hbsag) prevalence?
- Grenada ranks 82nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Grenada?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this Grenada data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).